Skip to content

BRUPHARMA: what changed

BE 0460.143.947NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2023 and 2024

Net result for the year
€23,906
2023 · -€14,290+€38,196
Equity
-€46,276
2023 · -€70,182+€23,906
Cash
€43,195
2023 · €91,860-€48,665
Balance sheet total
€727,515
2023 · €747,856-€20,341

Largest movements

2023 to 2024
Assets
  • Cash -€48,665

    down €48,665 (-53.0%), from €91,860 to €43,195

    mainly Tax, wage and social debts (-€65,280) and Trade debts (-€38,063)

  • Receivables within one year +€25,526

    up €25,526 (+17.9%), from €142,813 to €168,339

    of which Trade receivables: +€25,360

  • Tangible fixed assets -€10,791

    down €10,791 (-4.3%), from €252,363 to €241,572

    of which Land and buildings: -€11,448

  • Stocks and contracts +€9,627

    up €9,627 (+3.9%), from €247,570 to €257,197

Equity and liabilities
  • Other debts +€88,715

    up €88,715 (+57.8%), from €153,384 to €242,099

  • Tax, wage and social debts -€65,280

    down €65,280 (-59.2%), from €110,341 to €45,060

    of which Taxes: -€37,206

  • Trade debts -€38,063

    down €38,063 (-11.7%), from €324,843 to €286,780

  • Profit (loss) carried forward +€23,906

    up €23,906 (+18.1%), from -€132,156 to -€108,250

  • Debts after one year -€23,690

    down €23,690 (-11.9%), from €199,853 to €176,163

Income statement
  • Gross operating margin +€76,379

    up €76,379 (+19.8%), from €384,925 to €461,304

  • Staff costs +€22,451

    up €22,451 (+6.0%), from €375,035 to €397,487

  • Taxes +€7,882

    up €7,882 (+2,704%), from €291 to €8,173

  • Other operating charges +€5,612

    up €5,612 (+152%), from €3,686 to €9,297

Change in the result, 2023 to 2024

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2023 -€14,290
Gross operating margin +€76,379
Staff costs -€22,451
Depreciation -€3,120
Other operating charges -€5,612
Financial income +€5
Financial charges +€877
Taxes -€7,882
Result 2024 €23,906
raises the resultlowers the result

Derived cash bridge

cash 2023 to 2024

The bridge is derived from the 2023 and 2024 balance sheets and the 2024 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€14,595
Investment -€4,450
Financing -€29,619
Cash 2023 €91,860
Net result for the year +€23,906
Depreciation +€15,241
Stocks and contracts -€9,627
Receivables within one year -€25,526
Deferred charges and accrued income -€3,962
Trade debts -€38,063
Tax, wage and social debts -€65,280
Other debts +€88,715
Investment in fixed assets (net) -€4,450
Debts after one year -€23,690
Current portion of long-term debt -€40
Short-term financial debts -€5,890
Cash 2024 €43,195
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2023 2024 Change %
Total assets 20/58 €747,856 €727,515 -€20,341 -2.7%
Fixed assets 21/28 €252,482 €241,691 -€10,791 -4.3%
Tangible fixed assets 22/27 €252,363 €241,572 -€10,791 -4.3%
Land and buildings 22 €237,034 €225,586 -€11,448 -4.8%
Plant, machinery and equipment 23 - €3,917 +€3,917
Furniture and vehicles 24 €15,329 €12,068 -€3,261 -21.3%
Financial fixed assets 28 €119 €119 = 0.0%
Current assets 29/58 €495,375 €485,825 -€9,550 -1.9%
Stocks and contracts in progress 3 €247,570 €257,197 +€9,627 +3.9%
Stocks 30/36 €247,570 €257,197 +€9,627 +3.9%
Amounts receivable within one year 40/41 €142,813 €168,339 +€25,526 +17.9%
Trade receivables 40 €127,671 €153,031 +€25,360 +19.9%
Other amounts receivable 41 €15,142 €15,308 +€166 +1.1%
Cash at bank and in hand 54/58 €91,860 €43,195 -€48,665 -53.0%
Deferred charges and accrued income 490/1 €13,132 €17,094 +€3,962 +30.2%
Total equity and liabilities 10/49 €747,856 €727,515 -€20,341 -2.7%
Equity 10/15 -€70,182 -€46,276 +€23,906 +34.1%
Contributions 10/11 €61,973 €61,973 = 0.0%
Capital 10 €61,973 €61,973 = 0.0%
Issued capital 100 €61,973 €61,973 = 0.0%
Profit (loss) carried forward 14 -€132,156 -€108,250 +€23,906 +18.1%
Amounts payable 17/49 €818,039 €773,792 -€44,247 -5.4%
Amounts payable after more than one year 17 €199,853 €176,163 -€23,690 -11.9%
Financial debts 170/4 €199,853 €176,163 -€23,690 -11.9%
Amounts payable within one year 42/48 €618,186 €597,629 -€20,557 -3.3%
Current portion of amounts payable after more than one year 42 €23,730 €23,690 -€40 -0.2%
Financial debts 43 €5,890 - -€5,890
Credit institutions 430/8 €5,890 - -€5,890
Trade debts 44 €324,843 €286,780 -€38,063 -11.7%
Suppliers 440/4 €324,843 €286,780 -€38,063 -11.7%
Taxes, remuneration and social security 45 €110,341 €45,060 -€65,280 -59.2%
Taxes 450/3 €45,379 €8,173 -€37,206 -82.0%
Remuneration and social security 454/9 €64,961 €36,887 -€28,074 -43.2%
Other amounts payable 47/48 €153,384 €242,099 +€88,715 +57.8%
Non-recurring operating income 76A - €284 +€284
Remuneration, social security and pensions 62 €375,035 €397,487 +€22,451 +6.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €12,121 €15,241 +€3,120 +25.7%
Other operating charges 640/8 €3,686 €9,297 +€5,612 +152%
Gross operating margin 9900 €384,925 €461,304 +€76,379 +19.8%
Operating profit (loss) 9901 -€5,916 €39,279 +€45,195
Financial income 75/76B €0 €5 +€5 +13,450%
Recurring financial income 75 €0 €5 +€5 +13,450%
Financial charges 65/66B €8,083 €7,205 -€877 -10.9%
Recurring financial charges 65 €8,083 €7,205 -€877 -10.9%
Profit (loss) for the period before taxes 9903 -€13,999 €32,079 +€46,078
Income taxes 67/77 €291 €8,173 +€7,882 +2,704%
Profit (loss) for the period 9904 -€14,290 €23,906 +€38,196
Profit (loss) for the period to be appropriated 9905 -€14,290 €23,906 +€38,196

Value

latest balance sheet 31-12-2024 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€57,258 to €89,417

Midpoint €70,658 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity -€46,276
Capitalised earnings €160,793 to €225,110
Indication €57,258 to €89,417

Adjusted equity

balance sheet 31-12-2024
Equity (10/15)
-€46,276
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€46,276

Capitalised earnings

net result for the year (9904)
2024
€23,906
excluding non-recurring income and charges
€23,621
2023
-€14,290
2022
€58,202
2021
€46,619
2020
€31,239
Average result, excluding non-recurring income and charges
€22,511
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€160,793 / €187,592 / €225,110

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2023 and 31 December 2024. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.